Evidence map›Paper›PMID 28629334›Full record

ArticleBMC cancer2017

Protein kinase C-α (PKCα) modulates cell apoptosis by stimulating nuclear translocation of NF-kappa-B p65 in urothelial cell carcinoma of the bladder.

Jin Zheng, Chuize Kong, Xiaoxi Yang, Xiaolu Cui, Xuyong Lin, Zhe Zhang

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in BMC cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05941884 (Possible Diagnostic Protein Markers in Schistosoma Related Bladder Diseases.), which is not on this map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05941884 not yet recruitingnot on this mapstarted 2023, after this paper: background citation

Possible Diagnostic Protein Markers in Schistosoma Related Bladder Diseases.

TypeobservationalSponsorAssiut UniversityRan2023 to 2027Enrolled120ConditionsSchistosoma HaematobiumArmsImmunohistochemistry staining,, microscopic examination of urine
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Apoptosis and eryptosis: similarities and differences.Apoptosis : an international journal on programmed cell death · 2024
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Thrombin Induces COX-2 and PGEMediators of inflammation · 2022
    Article
  15. Article
  16. 6,6'-Dihydroxythiobinupharidine (DTBN) Purified fromMolecules (Basel, Switzerland) · 2021
    Article
  17. The complexities of PKCα signaling in cancer.Advances in biological regulation · 2021
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jin ZhengDepartment of Urology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, 110001, China. zhengjin@cmu1h.com.
Chuize KongDepartment of Urology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, 110001, China.
Xiaoxi YangDepartment of Cardiovascular, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, 110001, China.
Xiaolu CuiDepartment of Urology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, 110001, China.
Xuyong LinDepartment of Pathology, The First Affiliated Hospital and College of Basic Medical Sciences, China Medical University, Shenyang, Liaoning, 110001, China.
Zhe ZhangDepartment of Urology, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, 110001, China.
China Medical University · CNFirst Hospital of China Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe protein kinase C (PKC) family comprises central regulators of multiple signal transduction processes and is involved in the progression of many cancers. Nuclear factor Kappa-B (NF-κB) is constitutively expressed in cancer tissues and stimulates the transcription of various tumor-related genes. The present study aims to investigate the clinical significance of PKCα and NF-κB p65 in bladder cancer tissues and the mechanism underlying PKCα induction of bladder cancer cell apoptotic resistance through stimulation of p65 nuclear translocation.

methodsExpression of PKCα and NF-κB subunit p65 was detected in seven bladder cancer cell lines by western blot and in 30 bladder cancer tissue specimens by immunostaining. Immunofluorescence was performed to evaluate p65 nuclear translocation induced by Phorbol 12-myristate 13-acetate (PMA). PKCα/β selective inhibitor Gö6976, PKC pan-inhibitor sotrastaurin, and the PKC siRNA were employed to conduct PKC inhibition/knockdown in bladder cancer cells. Luciferase reporter assays were performed to measure the activity of NF-κB. Flow cytometry and TUNEL analysis were used to assess cell apoptosis.

resultsExpression of PKCα and NF-κB was found to positively correlate with tumor progression in 30 tumor tissue specimens. Furthermore, a Pearson's correlation coefficient analysis revealed a positive correlation between PKCα and NF-κB expression. Among the PKC inhibitors, the PKCα/β selective inhibitor Gö6976 yielded the most significant block of PKCα and NF-κB activation by PMA. Knockdown of NF-κB p65 remarkably induced cell apoptosis, but PMA restored p65 expression and significantly suppressed cell apoptosis that was otherwise induced by the p65 knockdown alone.

conclusionOur study showed that PKCα modulated cell resistance to apoptosis by stimulating NF-κB activation and thus promoted the tumorigenesis of bladder cancer.

Indexed as

ApoptosisActive Transport, Cell NucleusAdultAgedBiomarkersCarcinoma, Transitional CellCell Line, TumorFemaleGene ExpressionGene Expression ProfilingHumansMaleMiddle AgedNeoplasm GradingNeoplasm StagingProtein BindingBiomarkersProtein Kinase C-alphaTranscription Factor RelAApoptosisNF-κBPKCαUrothelial cell cancer

Identifiers

PMID28629334
PMCPMC5477139
OpenAlexW2626270245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.